Syrian Arab Republic vs Trinidad and Tobago: Hypertension effective treatment coverage (controlled hypertension)
Syrian Arab Republic
20.5%
in 2019
Trinidad and Tobago
20.9%
in 2019
Syrian Arab Republic rank
79th
Trinidad and Tobago rank
78th
Hypertension effective treatment coverage (controlled hypertension) over time
- Syrian Arab Republic
- Trinidad and Tobago
How they compare
Trinidad and Tobago currently reports 20.9% against 20.5% in Syrian Arab Republic, a difference of 0.4%.
Across all 30 years both countries report, Trinidad and Tobago has been ahead every year.
Syrian Arab Republic ranks 79th and Trinidad and Tobago ranks 78th of 193 countries.
Trinidad and Tobago has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Syrian Arab Republic | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 5.3% | 6.5% | 1.2% | Trinidad and Tobago |
| 2000s | 9.7% | 12.6% | 2.9% | Trinidad and Tobago |
| 2010s | 17.9% | 19.1% | 1.2% | Trinidad and Tobago |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension effective treatment coverage (controlled hypertension), Syrian Arab Republic or Trinidad and Tobago?
- Trinidad and Tobago, at 20.9% against 20.5% in Syrian Arab Republic as of 2019.
- What is the difference in hypertension effective treatment coverage (controlled hypertension) between Syrian Arab Republic and Trinidad and Tobago?
- 0.4%, with Trinidad and Tobago ahead.
- How many years of comparable data are there for Syrian Arab Republic and Trinidad and Tobago?
- 30 years are reported by both, from 1990 to 2019.
- How do Syrian Arab Republic and Trinidad and Tobago rank globally for hypertension effective treatment coverage (controlled hypertension)?
- Syrian Arab Republic ranks 79th and Trinidad and Tobago ranks 78th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension effective treatment coverage (controlled hypertension )among adults aged 30-79, age-standardized (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.